Literature DB >> 32529235

Hepatitis B or C prevalence in waste pickers from South America: a systematic review.

Gabriel Souza-Silva1, Marcos Paulo Gomes Mol1.   

Abstract

BACKGROUND: Waste pickers are considered a vulnerable population at risk for potential health damage. Taking into account the risk of hepatitis B or C infection in this population, the aim of this study was to show the prevalence of these diseases in waste pickers from South America, through a systematic review.
METHODS: The search covered publications until February 2020, accessed through Google Scholar database. Epidemiological studies on hepatitis B or C focused on waste pickers in South America were included. All selected papers were evaluated for quality.
RESULTS: Six studies composed this systematic review, all conducted in Brazil and using cross-sectional study. The prevalence of all makers (HBsAg or anti-HBc) for hepatitis B varied from 4.3 to 33.4% while for hepatitis C varied from 1.6 to 12.4%.
CONCLUSION: The lack of results showed the requirement for more research about hepatitis including this informal workers group. High prevalences of hepatitis B and C in waste pickers highlighted the need of increase preventive health protection as vaccination against hepatitis B; training on working conditions; and the use of individual protection.
© The Author(s) 2020. Published by Oxford University Press on behalf of Faculty of Public Health. All rights reserved. For permissions, please e-mail: journals.permissions@oup.com.

Entities:  

Keywords:  South America; hepatitis B; hepatitis C; prevalence; systematic review; waste pickers

Mesh:

Year:  2021        PMID: 32529235     DOI: 10.1093/pubmed/fdaa065

Source DB:  PubMed          Journal:  J Public Health (Oxf)        ISSN: 1741-3842            Impact factor:   2.341


  1 in total

1.  Hepatitis B prevalence in Brazilian waste pickers: a systematic review with meta-analysis.

Authors:  Gabriel Souza-Silva; Marcos Paulo Gomes Mol
Journal:  Rev Saude Publica       Date:  2021-11-26       Impact factor: 2.106

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.